Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PTGX
Stock Latest News
Ratings
Protagonist Therapeutics: Buy Rating Reiterated as Mimrylo Approval De-Risks Lead Asset; $186 Price Target Unchanged
4d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
4d ago
TAK
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $180 from $153 at Barclays
4d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $182 from $175 at Citi
5d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $170 from $165 at Citizens
5d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $170 from $167 at H.C. Wainwright
5d ago
TAK
PTGX
Premium
Ratings
Protagonist Therapeutics: Rusfertide Approval and Partnered Pipeline Underpin Buy Rating, $173 Price Target Reaffirmed
5d ago
PTGX
Premium
The Fly
Protagonist announces Takeda received U.S. FDA approval for MIMRYLO
6d ago
TAK
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
19d ago
JNJ
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $170 from $145 at Truist
26d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
26d ago
JNJ
PTGX
Premium
The Fly
Protagonist Therapeutics upgraded to Buy from Neutral at Goldman Sachs
26d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $175 from $130 at Citi
1M ago
PTGX
Premium
Ratings
Protagonist Therapeutics: Emerging Multi-Asset Revenue Streams and Robust Pipeline Drive Buy Rating Ahead of Rusfertide Approval
1M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $173 from $116 at Clear Street
1M ago
PTGX
Premium
Ratings
Protagonist Therapeutics: Diversified Pipeline Progress and Strong Cash Position Drive Buy Rating and Price Target Hike from $130 to $175
1M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $153 from $151 at Barclays
1M ago
PTGX
Premium
The Fly
Protagonist Therapeutics reports Q2 EPS $2.29, consensus $1.93
1M ago
PTGX
Premium
Company Announcements
Protagonist Therapeutics Highlights ICOTYDE Launch and Rusfertide Deal
1M ago
8K
PTGX
Premium
Company Announcements
PTGX’s PN-881 Phase 1 Completion: A Quiet Milestone With Big Pipeline Implications
1M ago
PTGX
Premium
Ratings
Analyst Tara Bancroft Boosts Protagonist Therapeutics Price Target to $155 on Stronger Icotyde Royalty Outlook and Buy Rating
2M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $165 from $137 at Citizens
2M ago
PTGX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
